Navigation Links
World Glaucoma Day Set for March 6th
Date:1/30/2008

First Annual Observance To Draw Attention To 'The Sneak Thief of Sight'

NEW YORK, Jan. 30 /PRNewswire/ -- In an effort to combat one of the main causes of blindness around the globe, the World Glaucoma Association and the World Glaucoma Patient Organization have announced the first annual World Glaucoma Day, to be observed on March 6, 2008. The day will be marked by awareness and educational events organized by glaucoma institutions and local patient support groups worldwide, as listed on http://www.wgday.net. As well as striking the residents of developing countries at alarming rates, glaucoma is the second leading cause of blindness in the United States and the leading cause for African-Americans.

Known as "the sneak thief of sight," glaucoma is a disease characterized by gradual loss of vision resulting from death of the cells in the eye which transmits visual images through the optic nerve to the brain. As the optic nerve becomes increasingly damaged, permanent vision loss and blindness can occur. Early detection is the key to treating and halting the effects of glaucoma, but current worldwide estimates reveal that more than half of glaucoma sufferers do not even realize they have the disease.

"Because glaucoma strikes so silently and gradually, it is absolutely crucial to educate people about the value of early detection," said Robert Ritch, MD, professor and chief of glaucoma services at The New York Eye and Ear Infirmary, co-founder of the World Glaucoma Patient Association, and member of the World Glaucoma Day committee for the World Glaucoma Association. "For a disease that causes permanent blindness, it is truly unacceptable that so many people remain unaware of its impact and consequences. Individuals in our country need to be much more vigilant about glaucoma, especially if they fall into one of the higher risk groups."

Persons at high risk for glaucoma should have their ey
'/>"/>

SOURCE World Glaucoma Day
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , 15 septembre 2014 La deuxième ... (IPAW) (semaine internationale sur la sensibilisation au ... Initiative conjointe de la Plasma Protein Therapeutics ... membres , l,IPAW vise à : ... de la collecte du plasma-aphérèse , Reconnaître ...
(Date:9/14/2014)... 2014 UMBC’s Biotechnology Graduate Programs’ ... October 21, 2014, from 12:00 to 1:00 p.m. EDT. ... innovative curriculum and practice-oriented instruction, designed for working professionals. ... help advance their career in the biotechnology industry. , ... , About UMBC’s Biotechnology Graduate Programs, UMBC offers ...
(Date:9/12/2014)... a magnet using an electric field (magnetoelectric memory ... the next-generation technology for information processing and storage. ... effect, due to the coexistence of electric and ... of spontaneous electric and magnetic polarizations is rare ... of the MEM effect. This article briefly reviews ...
(Date:9/12/2014)... September 12, 2014 Today, “The University” ... Indiegogo. , The film, directed by former Charlie ... Shimon Peres, Ashton Kutcher, Will.i.Am, Michio Kaku, and others. ... there’s only one university in the world devoted to ... the lives of a billion people: Singularity University. Matt ...
Breaking Biology Technology:L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2Documentary Film that Follows Singularity University Students as They Change the World Launches its IndieGoGo Fundraising Campaign 2
... SAN DIEGO , INDIANAPOLIS , and WALTHAM, Mass. , June ... Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ... of studies designed to test the superiority of BYDUREON™ (exenatide extended-release for injectable ... diabetes medications. , , , ...
... Inc. (Nasdaq: ISIS ) announced today that it will conduct the fourth ... Isis, development pipeline.  The last call of the series will focus on Isis, ... at 12:00 p.m. ET .  This call will be archived for a ... , , ...
... , June 15, 2010 Pieris AG,announced today the initiation ... PRS-050, an anti-VEGF Anticalin. The trial is an,open-label, dose-escalating evaluation of the ... in, Germany , the trial is underway and patients from the first ... , ...
Cached Biology Technology:DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 2DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 3DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 4DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 5DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 6DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 7DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 8DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment 9Isis Pharmaceuticals to Discuss Its Neurodegenerative Franchise in a Conference Call on Thursday, June 17 2Isis Pharmaceuticals to Discuss Its Neurodegenerative Franchise in a Conference Call on Thursday, June 17 3Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound 2
(Date:9/15/2014)... 2014 Schizophrenia is generally considered to be a ... factors, both genetic and environmental, with other neurodevelopmental disorders ... path for brain development is determined by the combined ... wide range of environmental factors. , However, longitudinal brain ... required in order to map the disturbances in brain ...
(Date:9/15/2014)... tip the balance between ridding the body of a ... a report appearing in The Journal of ... viruses cause chronic infections in roughly three-quarters of infected ... diseases including cirrhosis and cancer. A few patients successfully ... CD8 + T cells. The protective effects of ...
(Date:9/15/2014)... available in German . ... the fossil energy carrier natural gas offers a variety ... Nevertheless, a consequent market penetration is still pending because ... Scientists of the Helmholtz Centre for Environ-mental Research (UFZ) ... Members of the IEA Task 37 (Energy from Biogas) ...
Breaking Biology News(10 mins):Brain Development in Schizophrenia Strays from the Normal Path 2The biomethane market needs clear frame conditions for further growth 2The biomethane market needs clear frame conditions for further growth 3
... multicenter clinical trial led by a researcher at the ... will evaluate a new approach to treat triple-negative breast ... common among African-Americans and young women. The study will ... reprogram tumor cells to express a protein called an ...
... Institution (WHOI) will lead the first international, multidisciplinary assessment ... the Pacific Ocean off the Fukushima nuclear power planta ... Foundation. "This project will address fundamental ... to the ocean, and in the process enhance international ...
... can sometimes be desirable such as in the taste ... rejection that can interfere with food selection, nutrition and therapeutic ... the Monell Center and Integral Molecular describe the discovery of ... subset of bitter taste receptors. "Bitter taste is ...
Cached Biology News:New clinical trial to test novel approach to treat triple-negative breast cancer 2New clinical trial to test novel approach to treat triple-negative breast cancer 3Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 2Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 3Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 4Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 5New bitter blocker discovered 2
...
Request Info...
... vectors carry the kanamycin resistance gene that ... Spontaneous generation of multiple insertion events can ... of Geneticin Reagent. Pichia transformants are selected ... level of resistance to Geneticin Reagent. The ...
... Synthetic peptide derived from the C-terminal ... Math-2. Specificity: Specific for the ... (positive controls: human U251 A172 IMR-32 ... rat brain homogenates)Storage: Store at -20C ...
Biology Products: